Novartis is a publicly traded company trading on NYSE, led by CEO Vasant Narasimhan.
Upcoming earnings announcement for Novartis
Past 12 earnings reports for Novartis
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | Q4 2025 | $2.03Est: $2.00 | +1.5% | $13.3BEst: $13.9B | -4.2% | — |
| Oct 28, 2025 | Q3 2025 | $2.25Est: $2.29 | -1.7% | $13.9BEst: $13.9B | +0.3% | — |
| Jul 17, 2025 | Q2 2025 | $2.42Est: $2.38 | +1.7% | $14.1BEst: $14.1B | -0.1% | — |
| Apr 29, 2025 | Q1 2025 | $2.28Est: $2.08 | +9.6% | $13.2BEst: $13.0B | +1.9% | — |
| Jan 31, 2025 | Q4 2024 | $1.98Est: $1.79 | +10.6% | $13.2BEst: $12.8B | +3.0% | — |
| Oct 29, 2024 | Q3 2024 | $2.06Est: $1.96 | +5.1% | $12.8BEst: $12.7B | +1.0% | — |
| Jul 18, 2024 | Q2 2024 | $1.97Est: $1.86 | +5.9% | $12.5BEst: $12.3B | +1.9% | — |
| Apr 23, 2024 | Q1 2024 | $1.80Est: $1.69 | +6.5% | $11.8BEst: $11.5B | +3.0% | — |
| Jan 31, 2024 | Q4 2023 | $1.53Est: $1.68 | -8.9% | $11.4BEst: $11.6B | -1.2% | — |
| Oct 24, 2023 | Q3 2023 | $1.74Est: $1.70 | +2.4% | $11.8BEst: $11.4B | +3.4% | — |
| Jul 18, 2023 | Q2 2023 | $1.83Est: $1.66 | +10.2% | $13.6BEst: $13.2B | +3.4% | — |
| Apr 25, 2023 | Q1 2023 | $1.71Est: $1.55 | +10.3% | $13.0BEst: $12.6B | +2.5% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.